Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Differences in bile acids composition between ASCL5 knockout and floxed mice. (Study ST000694)

Reversed phase POSITIVE ION MODE (Analysis AN001074)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8
ADENINE (CAS# 73-24-5); (M+H)+	ME195179	0.70	1.58	0.38	NA	1.05	0.93	0.45	NA
ALANINE (CAS# 56-41-7); (M+H)+	ME195187	0.80	0.32	1.57	NA	NA	0.76	1.34	NA
5^-METHYLTHIOADENOSINE (CAS# 2457-80-9); (M+H)+	ME195160	0.38	1.02	1.14	NA	0.69	1.20	1.10	NA
2^-DEOXYINOSINE (CAS# 890-38-0); (M+NA)+	ME195115	0.28	1.33	1.07	NA	0.70	1.28	0.91	NA
3^-CMP (CAS# 63-37-6); (M+H)+	ME195127	1.39	0.93	0.38	NA	1.12	NA	0.90	NA
18:0 LYSO-PE (CAS# 69747-55-3); (M+H)+	ME195108	NA	1.05	0.61	NA	0.82	1.18	NA	NA
BETAINE (CAS# 107-43-7); (M+H)+	ME195207	0.63	1.00	0.88	NA	1.06	1.16	1.33	NA
20:0 LYSO PC (CAS# 108341-80-6); (M+NA)+	ME195124	1.04	0.89	1.37	NA	1.06	0.83	0.77	NA
5-OXOPROLINE (CAS# 4042-36-8); (M+H)+	ME195168	1.03	0.97	0.87	NA	0.88	1.50	0.58	NA
ALLANTOIN (CAS# 97-59-6); (M+H)+	ME195189	1.09	0.77	1.27	NA	1.24	0.64	1.34	NA
5ALPHA-CHOLEST-7-EN-3BETA-OL (CAS# 80-99-9); (M+H)+[-H2O]	ME195170	1.22	0.41	NA	NA	1.54	0.92	NA	NA
ALPHA-LINOLENIC ACID (CAS# 463-40-1); (M+NA)+	ME195192	1.24	1.02	0.97	NA	0.98	0.93	0.88	NA
3-METHYGLUTARIC ACID (CAS# 626-51-7); (M+NA)+	ME195140	NA	1.88	1.01	NA	NA	0.79	0.31	NA
ARABINOSE (CAS# 147-81-9); (M+NA)+	ME195194	0.93	0.97	1.06	NA	1.62	0.56	0.53	NA
1-AMINOCYCLOPROPANE-1-CARBOXYLATE (CAS# 22059-21-8); (M+H)+	ME195093	1.43	0.51	0.81	NA	1.42	0.91	0.55	NA
3-DEHYDROXYCARNITINE (CAS# 407-64-7); (M+H)+	ME195134	0.95	0.94	1.01	NA	1.02	0.65	1.26	NA
4-HYDROXY-3-METHOXY-BENZENEMETHANOL (CAS# 498-00-0); (M+H)+[-H2O]	ME195155	0.19	0.97	0.83	NA	0.22	1.45	0.61	NA
4-PYRIDOXATE (CAS# 82-82-6); (M+NA)+	ME195159	NA	1.07	1.13	NA	1.25	0.83	0.70	NA
2-HYDROXYPYRIDINE (CAS# 142-08-5); (M+H)+	ME195120	0.76	2.43	0.79	NA	0.18	0.58	1.69	NA
4-PYRIDOXATE (CAS# 82-82-6); (M+H)+	ME195157	NA	0.66	0.55	NA	0.40	1.69	0.82	NA
ABRINE (CAS# 526-31-8); (M+H)+	ME195174	0.51	0.74	0.80	NA	1.83	0.91	1.06	NA
4-HYDROXY-2-QUINOLINECARBOXYLIC ACID-KRYNURENIC ACID (CAS# 492-27-3); (M+H)+	ME195154	0.38	0.71	1.28	NA	0.21	1.94	1.12	NA
5-METHYLCYTOSINE (CAS# 554-01-8); (M+H)+	ME195167	1.83	0.28	1.17	NA	NA	0.62	NA	NA
5^-METHYLTHIOADENOSINE (CAS# 2457-80-9); (M+NA)+	ME195161	0.52	1.31	0.97	NA	0.80	1.20	1.14	NA
1-OLEOYL-RAC-GLYCEROL (CAS# 111-03-5); (M+NA)+	ME195099	0.83	1.17	0.29	NA	0.24	2.77	0.62	NA
16:0 LYSO PC (CAS# 17364-16-8); (M+H)+	ME195103	1.26	0.22	1.25	NA	1.24	0.67	0.97	NA
17BETA-HYDROXYANDROSTAN-3-ONE (CAS# 521-18-6); (M+NA)+	ME195106	0.80	1.28	1.14	NA	0.73	0.78	0.99	NA
3-METHYLADENINE (CAS# 5142-23-4); (M+H)+	ME195142	0.32	1.43	0.76	NA	0.47	2.41	0.66	NA
ALLANTOIN (CAS# 97-59-6); (M+NA)+	ME195190	1.46	0.99	0.54	NA	NA	1.01	NA	NA
2-METHYLPROPANAL OXIME (CAS# 151-00-8); (M+H)+[-H2O]	ME195122	1.17	0.42	0.96	NA	1.77	0.57	1.07	NA
2^-DEOXYGUANOSINE (CAS# 961-07-9); (M+NA)+	ME195112	NA	0.73	0.95	NA	0.17	1.27	1.68	NA
ASPARAGINE (CAS# 70-47-3); (M+H)+	ME195197	0.13	0.08	0.47	NA	0.57	NA	2.91	NA
AHBA (CAS# 76045-71-1); (M+H)+	ME195185	0.63	1.18	1.10	NA	0.53	1.46	0.78	NA
6-CARBOXYHEXANOATE (CAS# 111-16-0); (M+NA)+	ME195171	0.70	2.07	0.56	NA	1.42	0.61	0.93	NA
ASCORBATE (CAS# 50-81-7); (M+H)+[-H2O]	ME195196	1.39	2.24	0.18	NA	0.20	0.63	0.84	NA
2-HYDROXYBUTYRATE (CAS# ); (M+NA)+	ME195119	0.52	1.50	NA	NA	0.28	0.77	0.96	NA
4-AMINOBENZOATE (CAS# 150-13-0); (M+H)+	ME195150	1.18	0.94	0.22	NA	0.84	1.86	0.17	NA
ADIPIC ACID (CAS# 124-04-9 ); (M+NA)+	ME195182	NA	1.88	1.01	NA	NA	0.79	0.31	NA
1-OLEOYL-RAC-GLYCEROL (CAS# 111-03-5); (M+H)+[-H2O]	ME195098	2.44	0.43	0.84	NA	0.48	0.94	0.62	NA
2^-DEOXYINOSINE (CAS# 890-38-0); (2M+NA)+	ME195113	NA	0.59	0.59	NA	NA	2.33	1.23	NA
ASPARTATE (CAS# 56-84-8); (M+NA)+	ME195200	1.78	1.02	0.74	NA	NA	0.91	1.24	NA
AZELAIC ACID (CAS# 123-99-9); (M+NA)+	ME195202	0.68	1.30	0.80	NA	0.55	1.62	0.96	NA
5-AMINOPENTANOATE (CAS# 660-88-8); (M+H)+	ME195162	0.64	1.03	0.90	NA	1.09	1.03	1.35	NA
3-METHYLADIPIC ACID (CAS# 3058-01-3); (M+NA)+	ME195143	0.92	0.97	0.63	NA	1.15	1.04	1.07	NA
16:0 LYSO PC (CAS# 17364-16-8); (M+NA)+	ME195104	1.14	0.33	1.43	NA	1.33	0.55	1.21	NA
2^-DEOXYINOSINE (CAS# 890-38-0); (M+H)+	ME195114	NA	0.11	2.13	NA	NA	0.98	0.56	NA
BETA-ALANINE (CAS# 107-95-9); (M+H)+	ME195203	1.18	0.99	0.70	NA	1.68	0.33	0.96	NA
4-PYRIDOXATE (CAS# 82-82-6); (M+H)+[-H2O]	ME195158	0.75	1.14	0.52	NA	NA	1.88	0.38	NA
ADP-RIBOSE (CAS# ); (M+H)+[-H2O]	ME195183	NA	NA	0.33	NA	0.41	2.32	0.96	NA
ADENOSINE 5^-MONOPHOSPHATE (CAS# 61-19-8); (M+H)+	ME195181	1.15	1.01	1.06	NA	0.99	0.33	1.03	NA
2^-DEOXYGUANOSINE (CAS# 961-07-9); (M+H)+	ME195111	NA	0.49	0.90	NA	0.30	1.76	0.71	NA
2-METHYLGLUTARIC ACID (CAS# 18069-17-5); (M+NA)+	ME195121	NA	1.73	1.03	NA	NA	0.92	0.29	NA
3-HYDROXYPROPANOATE (CAS# 503-66-2); (M+NA)+	ME195138	1.08	0.97	1.71	NA	0.91	0.57	0.49	NA
4-GUANIDINOBUTANOATE (CAS# 463-00-3 ); (M+H)+	ME195153	1.43	0.43	0.82	NA	1.44	0.90	0.76	NA
ADENOSINE (CAS# 58-61-7); (M+H)+	ME195180	NA	0.49	0.90	NA	0.30	1.74	0.72	NA
(2-AMINOETHYL)PHOSPHONATE (CAS# 2041-14-7); (M+NA)+	ME195089	NA	1.56	1.93	NA	0.21	0.72	0.76	NA
5-METHYLCYTOSINE (CAS# 554-01-8); (2M+H)+	ME195166	2.17	1.36	0.95	NA	0.99	NA	0.17	NA

Factors:

F1	Genotype:FLOX \| Intestinal Segment:Duodenum
F2	Genotype:FLOX \| Intestinal Segment:Illeum
F3	Genotype:FLOX \| Intestinal Segment:Jejunum
F4	Genotype:- \| Intestinal Segment:-
F5	Genotype:Knockout \| Intestinal Segment:Duodenum
F6	Genotype:Knockout \| Intestinal Segment:Illeum
F7	Genotype:Knockout \| Intestinal Segment:Jejunum
F8	Genotype:Pooled flushing \| Intestinal Segment:Pooled flushing

Data matrix